Gene therapy as a treatment of oral cancer: An insight
- PMID: 37854908
- PMCID: PMC10581311
- DOI: 10.4103/jomfp.jomfp_46_23
Gene therapy as a treatment of oral cancer: An insight
Abstract
Oral cancer or oral squamous cell carcinoma comprises more than three-fourth of all the malignant neoplasms of the oral cavity. Worldwide, it is the 18th most common malignancy. The patients suffering from cancer usually remains immune to the standard therapies such as surgical resection of tumours, radiotherapy and chemotherapy; however, there can be probabilities of chronic and acute toxicities and secondary malignancies as well. Recently, gene therapy has been introduced in the arena of biomedicine to improve the treatment modality for oral malignant and potentially malignant disorders. It replaces the defective gene followed by repairing by a therapeutic gene. Gene therapy can attack cancerous cells without causing harmful effect to the normal tissue. It is useful to cope with the relapse of diseases and as a synergetic treatment. The present article reviewed the types of gene therapy, modes of delivery of the therapeutic genes and different techniques used along with pros and cons of gene therapy.
Keywords: Gene therapy; nanoparticles; oral squamous cell carcinoma (OSCC).
Copyright: © 2023 Journal of Oral and Maxillofacial Pathology.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.Drugs R D. 2007;8(3):176-87. doi: 10.2165/00126839-200708030-00005. Drugs R D. 2007. PMID: 17472413 Review.
-
Immune Checkpoint Inhibitors in Oral Cavity Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review.Cancers (Basel). 2020 Jul 17;12(7):1937. doi: 10.3390/cancers12071937. Cancers (Basel). 2020. PMID: 32708945 Free PMC article. Review.
-
Controlled Drug Delivery Systems for Oral Cancer Treatment-Current Status and Future Perspectives.Pharmaceutics. 2019 Jun 30;11(7):302. doi: 10.3390/pharmaceutics11070302. Pharmaceutics. 2019. PMID: 31262096 Free PMC article. Review.
-
The use of topical ALA-photodynamic therapy combined with induction chemotherapy for locally advanced oral squamous cell carcinoma.Am J Otolaryngol. 2021 Nov-Dec;42(6):103112. doi: 10.1016/j.amjoto.2021.103112. Epub 2021 Jun 17. Am J Otolaryngol. 2021. PMID: 34214712
-
A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.Arch Oral Biol. 2021 Sep;129:105203. doi: 10.1016/j.archoralbio.2021.105203. Epub 2021 Jun 30. Arch Oral Biol. 2021. PMID: 34252587
Cited by
-
Harnessing State-of-the-Art Gene Therapy to Transform Oral Cancer Treatment.Biochem Genet. 2025 Mar 11. doi: 10.1007/s10528-025-11078-3. Online ahead of print. Biochem Genet. 2025. PMID: 40067653 Review.
References
-
- Sudbø J, Reith A. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int J Cancer. 2005;115:339–45. - PubMed
-
- Chaudhary N, Gupta DK, Verma RK, Choudhary SR. Squamous cell carcinoma of tongue in a 12- year-old child. Acta Otolaryngol Case Rep. 2016;1:87–9.
-
- Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people-A comprehensive literature review. Oral Oncol. 2001;37:401–18. - PubMed
-
- Sunil PM, Joseph I, Varghese SS. Gene therapy in oral squamous cell carcinoma – A short review. Oral Maxillofac Pathol J. 2011;2:142–7.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous